MLICM
OMCL icon

Metropolitan Life Insurance Company (MetLife)’s Omnicell OMCL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,390
Closed -$69.9K – 1462
2024
Q1 		$69.9K Sell
2,390
-200
-8% -$6.06K ﹤0.01% 1244
2023
Q4 		$97.5K Hold
2,590
– – ﹤0.01% 1100
2023
Q3 		$117K Buy
2,590
+127
+5% +$7.69K 0.01% 927
2023
Q2 		$181K Hold
2,463
– – 0.01% 722
2023
Q1 		$145K Sell
2,463
-281
-10% -$15.5K 0.01% 806
2022
Q4 		$138K Buy
2,744
+97
+4% +$5.83K 0.01% 888
2022
Q3 		$230K Hold
2,647
– – 0.01% 629
2022
Q2 		$301K Sell
2,647
-95
-3% -$10.9K 0.01% 567
2022
Q1 		$355K Sell
2,742
-8,363
-75% -$1.21M 0.01% 600
2021
Q4 		$2M Sell
11,105
-242
-2% -$42K 0.03% 529
2021
Q3 		$1.68M Sell
11,347
-579
-5% -$88.7K 0.02% 601
2021
Q2 		$1.81M Buy
11,926
+761
+7% +$106K 0.03% 577
2021
Q1 		$1.45M Sell
11,165
-1,010
-8% -$130K 0.02% 713
2020
Q4 		$1.46M Hold
12,175
– – 0.02% 640
2020
Q3 		$909K Sell
12,175
-792
-6% -$54.9K 0.02% 801
2020
Q2 		$916K Buy
12,967
+360
+3% +$24.6K 0.02% 784
2020
Q1 		$827K Sell
12,607
-474
-4% -$37.8K 0.02% 778
2019
Q4 		$1.07M Sell
13,081
-189
-1% -$14.5K 0.02% 857
2019
Q3 		$959K Buy
13,270
+703
+6% +$51.6K 0.02% 880
2019
Q2 		$1.08M Buy
12,567
+269
+2% +$21.9K 0.02% 849
2019
Q1 		$994K Sell
12,298
-180
-1% -$13.5K 0.02% 880
2018
Q4 		$764K Buy
12,478
+164
+1% +$11.1K 0.02% 952
2018
Q3 		$885K Hold
12,314
– – 0.02% 998
2018
Q2 		$646K Hold
12,314
– – 0.01% 1150
2018
Q1 		$534K Buy
12,314
+278
+2% +$12.8K 0.01% 1231
2017
Q4 		$584K Sell
12,036
-12,447
-51% -$628K 0.01% 1183
2017
Q3 		$1.25M Hold
24,483
– – 0.01% 1128
2017
Q2 		$1.05M Buy
24,483
+389
+2% +$16.2K 0.01% 1224
2017
Q1 		$979K Sell
24,094
-772
-3% -$28.5K 0.01% 1247
2016
Q4 		$843K Sell
24,866
-2,414
-9% -$83K 0.01% 1391
2016
Q3 		$1.04M Sell
27,280
-807
-3% -$30.1K 0.01% 1252
2016
Q2 		$961K Sell
28,087
-424
-1% -$13.2K 0.01% 1280
2016
Q1 		$795K Buy
28,511
+4,103
+17% +$113K 0.01% 1292
2015
Q4 		$759K Hold
24,408
– – 0.01% 1340
2015
Q3 		$759K Sell
24,408
-3,220
-12% -$115K 0.01% 1344
2015
Q2 		$1.04M Sell
27,628
-1,956
-7% -$71.3K 0.01% 1256
2015
Q1 		$1.04M Hold
29,584
– – 0.01% 1174
2014
Q4 		$980K Hold
29,584
– – 0.01% 1328
2014
Q3 		$809K Hold
29,584
– – 0.01% 1405
2014
Q2 		$849K Buy
29,584
+969
+3% +$26.2K 0.01% 1466
2014
Q1 		$819K Buy
28,615
+1,834
+7% +$50.2K 0.01% 1485
2013
Q4 		$684K Buy
26,781
+30
+0.1% +$716 ﹤0.01% 1593
2013
Q3 		$633K Sell
26,751
-2,101
-7% -$46.8K ﹤0.01% 1594
2013
Q2 		$593K Buy
+28,852
New +$533K ﹤0.01% 1586

Other funds holding OMCL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s OMCL Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Omnicell (OMCL) in Q2 2024, closing a stake of 2,390 shares — an estimated $69.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OMCL in Q2 2013 and held it in 44 quarters. The position peaked at $2M in Q4 2021. 241 funds tracked by Wall St. Rank hold OMCL as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Omnicell position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,390 Omnicell shares in Q2 2024, an estimated $69.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Omnicell in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Omnicell position peaked at $2M in Q4 2021.
  • 241 funds tracked by Wall St. Rank held Omnicell as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.